Patents Assigned to Schering Akitiengesellschaft
  • Therapeutic Gestagens For The Treatment Of Premenstrual Dysphoric Disorder
    Publication number: 20130225542
    Abstract: This invention describes the use of a therapeutic gestagen (e.g., drospirenone, cyproterone acetate, dienogest) for the production of a pharmaceutical agent for the treatment of premenstrual dysphoric disorder (PMDD), optionally in combination with a natural or synthetic estrogen (e.g., estradiol or ethinylestradiol).
    Type: Application
    Filed: February 1, 2013
    Publication date: August 29, 2013
    Applicant: SCHERING AKITIENGESELLSCHAFT
    Inventor: Schering Akitiengesellschaft
  • Combination contraceptive
    Patent number: 6225297
    Abstract: This invention relates to a combination product that consists of individual dosage units of a competitive progesterone antagonist and, in addition, sequentially provided individual dosage units of a compound with gestagenic action, as well as its use for the production of contraceptives based on the inhibition of implantation (receptivity inhibition).
    Type: Grant
    Filed: November 1, 1996
    Date of Patent: May 1, 2001
    Assignee: Schering Akitiengesellschaft
    Inventors: Klaus Stockemann, Kristof Chwalisz